Processa Pharmaceuticals 미래 성장
Future 기준 확인 0/6
Processa Pharmaceuticals's earnings are forecast to decline at 9.6% per annum. EPS is expected to grow by 53.4% per annum.
주요 정보
-9.6%
수익 성장률
53.4%
EPS 성장률
Pharmaceuticals 수익 성장 | 23.7% |
매출 성장률 | n/a |
향후 자기자본 수익률 | n/a |
애널리스트 커버리지 | Low |
마지막 업데이트 | 03 Oct 2024 |
최근 미래 성장 업데이트
Recent updates
We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully
Dec 12Will Processa Pharmaceuticals (NASDAQ:PCSA) Spend Its Cash Wisely?
Oct 20Processa Pharmaceuticals GAAP EPS of $0.53 beats by $0.73
Aug 12We Think Processa Pharmaceuticals (NASDAQ:PCSA) Needs To Drive Business Growth Carefully
Jul 07We're Not Very Worried About Processa Pharmaceuticals' (NASDAQ:PCSA) Cash Burn Rate
Jan 20Processa Pharmaceuticals (NASDAQ:PCSA) Is In A Good Position To Deliver On Growth Plans
Aug 26Processa Pharmaceuticals (PCSA) Presents At LD Micro Invitations XI Virtual Conference - Slideshow
Jun 15What Percentage Of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Do Insiders Own?
Mar 15Processa Pharmaceuticals: Multiple Shots On Goal With Total TAM Of $8B - Worth A Look
Jan 29How Many Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Shares Did Insiders Buy, In The Last Year?
Jan 20수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
12/31/2025 | N/A | -13 | N/A | N/A | 1 |
12/31/2024 | N/A | -12 | N/A | N/A | 1 |
9/30/2024 | N/A | -12 | -11 | -11 | N/A |
6/30/2024 | N/A | -10 | -9 | -9 | N/A |
3/31/2024 | N/A | -10 | -8 | -8 | N/A |
12/31/2023 | N/A | -11 | -8 | -8 | N/A |
9/30/2023 | N/A | -22 | -8 | -8 | N/A |
6/30/2023 | N/A | -26 | -10 | -10 | N/A |
3/31/2023 | N/A | -28 | -10 | -10 | N/A |
12/31/2022 | N/A | -27 | -10 | -10 | N/A |
9/30/2022 | N/A | -18 | -10 | -10 | N/A |
6/30/2022 | N/A | -15 | -8 | -8 | N/A |
3/31/2022 | N/A | -13 | -8 | -8 | N/A |
12/31/2021 | N/A | -11 | -9 | -9 | N/A |
9/30/2021 | N/A | -23 | -8 | -8 | N/A |
6/30/2021 | N/A | -23 | -7 | -7 | N/A |
3/31/2021 | N/A | -20 | -5 | -5 | N/A |
12/31/2020 | N/A | -19 | -3 | -3 | N/A |
9/30/2020 | N/A | -6 | -1 | -1 | N/A |
6/30/2020 | N/A | -4 | -2 | -2 | N/A |
3/31/2020 | N/A | -4 | -3 | -3 | N/A |
12/31/2019 | N/A | -4 | -3 | -3 | N/A |
9/30/2019 | N/A | -3 | -3 | -3 | N/A |
6/30/2019 | N/A | -3 | -3 | -3 | N/A |
3/31/2019 | N/A | -3 | -3 | -3 | N/A |
12/31/2018 | N/A | -4 | -4 | -4 | N/A |
9/30/2018 | N/A | -4 | -4 | -4 | N/A |
6/30/2018 | N/A | -4 | N/A | -4 | N/A |
3/31/2018 | N/A | -3 | N/A | -3 | N/A |
12/31/2017 | N/A | -2 | N/A | -2 | N/A |
12/31/2016 | N/A | -2 | N/A | -2 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: PCSA is forecast to remain unprofitable over the next 3 years.
수익 vs 시장: PCSA is forecast to remain unprofitable over the next 3 years.
고성장 수익: PCSA is forecast to remain unprofitable over the next 3 years.
수익 대 시장: Insufficient data to determine if PCSA's revenue is forecast to grow faster than the US market.
고성장 수익: PCSA is forecast to have no revenue next year.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: Insufficient data to determine if PCSA's Return on Equity is forecast to be high in 3 years time